Report ID: 10070475 |
Published Date: 21 Mar 2025 |
Report Format: |
Delivery Timeline: 48-72 Business Hours
Global Viscosupplementation Market Highlights Over 2022 - 2031
The global viscosupplementation market is estimated to garner around USD 4 billion in revenue by 2031 by growing at a CAGR of nearly 8% over the forecast period, i.e., 2022 – 2031. The growth of the market can be attributed to the rising prevalence of osteoarthritis among the geriatric population, and the increasing demand for minimally invasive surgeries. For instance, according to the Global Health and Aging report by the World Health Organization (WHO), an estimated number of people, aged 65 and above, is projected to increase from 524 million in 2010 to nearly 1.5 billion in 2050. Additionally, increasing government initiatives, and rising investments by the key companies in viscosupplementation are expected to further boost the market growth in the upcoming years.
CLICK TO DOWNLOAD A SAMPLE REPORT
The COVID-19 pandemic had led to a decrease in the demand for viscosupplementation devices as government-imposed lockdowns led to a decrease in regular check-ups related to osteoarthritis. Further, various forms of procedures were temporarily stopped, as COVID-19 patients were given the utmost priority.
However, the high cost associated with the treatment, and lack of inefficiency and safety of the products are the key factors restraining the growth of the market.
The market is segmented by product into single injection, three injections, and five injections. Among these segments, the three-injection segment is anticipated to hold the major share over the forecast period on the back of the preference by medical practitioners referring patients to adopt three injection treatments to avoid total knee replacement surgery in case of osteoarthritis.
Global Viscosupplementation Market Regional Synopsis
Regionally, the global viscosupplementation market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. The market in North America region is estimated to witness significant growth over the forecast period on the back of the introduction of enhanced new drugs related to viscosupplementation, and high prevalence of osteoarthritis in countries, such as the U.S. For instance, according to the ‘Arthritis By The Numbers’ report by Arthiritis Foundation in the United States, it was estimated that the number of adults in the U.S. with doctor-diagnosed arthritis is expected to be nearly 78.4 million by 2040, which is 25.9 percent of all adults in the country.
Asia Pacific region is predicted to witness the highest growth during the forecast period owing to the rapidly increasing population, and rising healthcare expenditure. Additionally, the low cost of manufacture of medicines and injections in China and India has resulted in attracting pharmaceutical and biotechnological companies into region. This factor is further expected to boost the market growth in the region.
Market Segmentation
Our in-depth analysis of the global viscosupplementation market includes the following segments:
By Product
-
Single Injection
-
Three Injection
-
Five Injection
By Application
-
Knee Osteoarthritis
-
Hip Osteoarthritis
-
Hand Osteoarthritis
By Source
-
Animal
-
Non Animal
By End User
-
Hospitals
-
Orthopedic Clinics
-
Ambulatory Surgical Centers
-
Others
Growth Drivers and Challenges Impacting the Growth of the Global Viscosupplementation Market
Growth Drivers
-
Rising prevalence of osteoarthritis among geriatric population
-
Increasing demand for minimally invasive surgeries
Challenges
-
High cost associated with the treatment
-
Lack of efficiency and safety of the products
Key Companies Dominating the Global Viscosupplementation Market
Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the global viscosupplementation market that are included in our report are SEIKAGAKU CORPORATION, Anika Therapeutics, Inc., Bioventus, Ferring B.V., Sanofi, Lifecore, KiOmed Pharma, LG Chem, Smith & Nephew, Avanos Medical, Inc., and others.
Latest Developments in the Global Viscosupplementation Market:
-
August 2021: SEIKAGAKU CORPORATION launched HyLink, an intra-articular single-injection viscosupplement for knee osteoarthritis treatment in Taiwan.
-
January 2019: OrthogenRx, Inc. (Avanos Medical, Inc.) launched TriVisc (sodium hyaluronate) for the treatment of knee osteoarthritis pain in a 3-injection regimen.
Key Reasons to Buy Our Report
-
The report covers detailed analysis comprising market share attained by each market segment and its sub-segments.
-
It covers market dynamics including growth drivers, trends, potential opportunities, price trend analysis and challenges that impact the market growth.
-
The report includes detailed company profiles of the major players dominating the market.
-
We use effective research methodologies to calculate the market numbers and provide value-added assessment for overall growth.
-
We provide customized reports as per the clients’ requirement helping them to see possible and unexpected challenges and unforeseen opportunities in order to help them reach their goal.
Frequently Asked Question
The market is segmented by product, application, source, end user, and by region.
The three injection segment is anticipated to hold largest market size in value and display significant growth opportunities.
Why Choose Kenneth Research ?
-
Insight with Impact : We don’t just gather data — we uncover stories, trends, and opportunities that fuel business growth.
-
Experts Who Get It : Our team speaks your industry’s language and knows what really matters to your customers and market.
-
Custom-Built for You : Forget one-size-fits-all. We craft research and consulting solutions as unique as your business vision.
-
Partners, Not Just Providers : We work with you, not for you — collaborating closely to turn insights into smart, strategic moves.
-
Results That Speak : Our work powers brands, startups, and industry leaders alike — with a track record of ideas that work in the real world.
Report ID: 10070475 |
Published Date: 21 Mar 2025 |
Report Format: |
Delivery Timeline: 48-72 Business Hours
